|
May 13
|
15 Most Depressed States in the US
|
|
May 7
|
Sage Therapeutics to Participate in Upcoming May Investor Conferences
|
|
Apr 30
|
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript
|
|
Apr 28
|
Earnings Update: Sage Therapeutics, Inc. (NASDAQ:SAGE) Just Reported And Analysts Are Boosting Their Estimates
|
|
Apr 26
|
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
|
|
Apr 26
|
Sage Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Apr 25
|
Sage Therapeutics Inc (SAGE) Q1 2024 Earnings: Mixed Results Amidst Pipeline Progress
|
|
Apr 25
|
Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates
|
|
Apr 25
|
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
|
|
Apr 18
|
Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
|
|
Apr 18
|
Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Apr 17
|
Sage Stock Collapses To Record Low After Parkinson's Drug Misses Its Mark
|
|
Apr 17
|
Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data
|
|
Apr 17
|
Sage’s cognition drug fails in Parkinson’s study
|
|
Apr 17
|
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
|
|
Apr 11
|
12 Best All-Time Low Stocks To Invest In
|
|
Apr 11
|
Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024
|
|
Apr 10
|
12 Best Depressed Stocks To Buy in 2024
|
|
Apr 10
|
New postpartum depression drugs are here. Diagnosis, treatment hurdles still stand in the way.
|
|
Mar 28
|
We're Keeping An Eye On Sage Therapeutics' (NASDAQ:SAGE) Cash Burn Rate
|